Applovin screens cheaper on two of the three valuation measures provided, while Synopsys has the lower price-to-book ratio. The results are mixed, so there’s no clear value winner.
Synopsys Inc. (SNPS) and Applovin Corp. (APP) are both in the Information Technology sector and Software & Services industry group. In the October 30, 2026 snapshot, their latest adjusted closes were US$467.61 and US$228.50, respectively. Share prices alone don’t show which stock is cheaper. Applovin has the lower P/E and PEG ratios, while Synopsys has the lower P/B ratio. Here’s what that comparison tells us—and what it doesn’t.
Investor takeaway: Applovin has the lower figure on two of the three supplied measures: P/E, PEG and P/B. Synopsys is lower on the third. That’s a split result, not a reason to call either stock a clear value pick. Valuation multiples are only one part of an investment assessment. They don’t establish business quality, future returns or whether a stock suits your circumstances.
Stocks in this list
Live snapshots — open any name for the full quote and Wealth Awesome price forecast.
Synopsys Inc
SNPS.US
Information Technology
$467.61
$89.61B
1D
-4.61%
1W
+8.71%
Applovin Corp
APP.US
Information Technology
$228.50
$76.47B
1D
-10.36%
1W
-12.20%
Applovin is lower on two of three supplied multiples
Applovin’s P/E is 17.6, compared with 82.6 for Synopsys. Its PEG is 0.50, versus 2.43 for Synopsys. But Synopsys has the lower P/B: 2.88, compared with 24.22 for Applovin. The measures point in different directions, and this snapshot doesn’t show which one better reflects each company’s future prospects.
Bull case
Applovin, the lower-priced company on P/E and PEG, also reports TTM ROE of 203.7% in the snapshot. That figure provides context, but it doesn’t prove the stock is attractively valued or that the result is sustainable.
Bear case
Applovin’s P/B of 24.22 is much higher than Synopsys’ 2.88. The snapshot doesn’t explain the gap or show whether book value is a useful comparison for either company.
The valuation table is split
Applovin has the lower P/E and PEG, while Synopsys has the lower P/B. Neither company has the lower figure across all three measures.
| Measure | Synopsys (SNPS) | Applovin (APP) | Lower figure |
|---|---|---|---|
| P/E | 82.6 | 17.6 | Applovin |
| PEG | 2.43 | 0.50 | Applovin |
| P/B | 2.88 | 24.22 | Synopsys |
For more company-specific information, see Synopsys stock and Applovin stock. These figures are a snapshot, not a complete valuation model. They don’t capture every difference between the companies or establish what either stock is worth.
Other snapshot figures add context, not a verdict
Synopsys has a reported market cap of US$89.6B, compared with US$76.5B for Applovin. Both have a reported dividend yield of 0.00%. TTM ROE is 3.7% for Synopsys and 203.7% for Applovin. These figures describe different aspects of the companies, but the snapshot doesn’t explain what caused them or how they might change.
The supplied table lists analyst consensus ratings of Strong Buy for Synopsys and Buy for Applovin, with price targets of US$586.95 and US$448.43, respectively. Ratings and targets aren’t guarantees or proof that a stock is good value. Overall, the comparison remains mixed: Applovin has the lower figure on two supplied valuation measures, while Synopsys has the lower P/B.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
